Wegovy is FDA-approved specifically for weight management at a dose of 2.4 mg weekly, while Ozempic is approved only for type 2 diabetes at lower doses
Through gut microbiota modulation, probiotics from the genera Bifidobacterium and Lactobacillus have demonstrated efficacy in controlling cholesterol levels in clinical studies ( Bacteroides spp., and Akkermansia show promise in specifically lowering cholesterol levels (Verhaar et al., 2020)
Given the lucrative potential of these drugs, the GLP-1 market, also known as GLP-1 receptor agonist market, has gained significant attention of both private and public investors leading to the substantial market growth during the forecast period
Yang S-H, Xu R-X, Cui C-J, Wang Y, Du Y, Chen Z-G, et al